Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Novartis gets FDA panel backing for biosimilar Enbrel

Novartis gets FDA panel backing for biosimilar Enbrel The Japanese drugmaker gains exclusive commercialisation rights to nine drugs in Amgen's biosimilar pipeline, including its Humira clone and copies of Roche's anticancer drugs Avastin (bevacizumab) and Herceptin (trastuzumab).

Lilly and Boehringer combine breast cancer drugs in trial

Lilly and Boehringer combine breast cancer drugs in trial Herceptin (trastuzumab).

European pharma ‘to grow 3.2% per year by 2022’

European pharma ‘to grow 3.2% per year by 2022’ Cancer treatments are set to provide five compounds in the top 10 in 2022, although Roche's Herceptin (2015 sales of 2.117 bn to 2022 sales of 1.383 bn) ... Among these is Mylan and Biocon's MYL-1401O, whose data was shown to be comparable in efficacy

Biosimilar trastuzumab comparable to brand, ASCO hears

Biosimilar trastuzumab comparable to brand, ASCO hears Roche’s Herceptin matched in safety and efficacy by Mylan and Biocon’s breast cancer drug. ... The 500-patient trial compared MYL-1401O to Herceptin - both given alongside a minimum of eight cycles of standard taxane-based chemotherapy - until the

Daiichi pulls study of patritumab in lung cancer

Daiichi pulls study of patritumab in lung cancer HER3 (also known as ErbB3) is another member of the HER (human epidermal growth factor receptor) family targeted by established drugs such as Roche's Herceptin (trastuzumab), which binds to HER2.

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics